LC– and CZE–ICP-MS approaches for the in vivo analysis of the anticancer drug candidate sodium trans-[tetrachloridobis(1H-indazole)ruthenate(iii)] (KP1339) in mouse plasma†
Abstract
Ruthenium–
Maintenance work is planned from 09:00 BST to 12:00 BST on Saturday 28th September 2024.
During this time the performance of our website may be affected - searches may run slowly, some pages may be temporarily unavailable, and you may be unable to access content. If this happens, please try refreshing your web browser or try waiting two to three minutes before trying again.
We apologise for any inconvenience this might cause and thank you for your patience.
* Corresponding authors
a
University of Vienna, Institute of Inorganic Chemistry, Waehringer Str. 42, A-1090 Vienna, Austria
E-mail:
christian.hartinger@univie.ac.at
Fax: +43-1-4277-52609
b
University of Natural Resources and Life Sciences, Muthgasse 18, A-1180 Vienna, Austria
E-mail:
gunda.koellensperger@boku.ac.at
Fax: +43-1-47654-6087
c University of Vienna, Research Platform Translational Cancer Therapy Research, Waehringer Str. 42, A-1090 Vienna, Austria
Ruthenium–
Fetching data from CrossRef.
This may take some time to load.
Loading related content